Efficacy and safety of an inactivated virus-particle vaccine for SARS-CoV-2, BIV1-CovIran: randomised, placebo controlled, double blind, multicentre, phase 3 clinical trial

por Mohraz, Minoo, Vahdat, Katayoun, Ghamari, Seyyed-Hadi, Abbasi-Kangevari, Mohsen, Ghasemi, Erfan, Ghabdian, Yasaman, Rezaei, Negar, Pouya, Maryam Amini, Abdoli, Asghar, Malekpour, Mohammad-Reza, Koohgir, Keyvan, Saeedi Moghaddam, Sahar, Tabarsi, Payam, Moghadami, Mohsen, Khorvash, Farzin, Khodashahi, Rozita, Salehi, Mohammadreza, Hosseini, Hamed
Publicado 2023